US Pharma MarketingAmgen channels another $300M into US outlay, bolstering Puerto Rico biologics expansion
After topping up its long-running operations in Puerto Rico last year, Amgen is infusing $300 million more into the U.S. territory.
After topping up its long-running operations in Puerto Rico last year, Amgen is infusing $300 million more into the U.S. territory.
Source: FiercePharma